The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a Difference

Raymond J. Pierce*, Jane MacDougall, Rob Leurs, Maria Paola Costi

*Corresponding author for this work

Research output: Contribution to JournalShort surveyAcademicpeer-review

31 Downloads (Pure)

Abstract

In this article, the four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved.

Original languageEnglish
Pages (from-to)581-583
Number of pages3
JournalTrends in Parasitology
Volume33
Issue number8
Early online date18 May 2017
DOIs
Publication statusPublished - Aug 2017

Funding

FundersFunder number
Seventh Framework Programme603240

    Fingerprint

    Dive into the research topics of 'The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a Difference'. Together they form a unique fingerprint.

    Cite this